Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: A two-year prospective study

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 6, 2003, Pages 1401-1405

  Guido, Richard ^a   Schiffman, Mark ^b   Solomon, Diane ^c   Burke, Louis ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cervical intraepithelial neoplasia grade 1; Cervix; Clinical management; Colposcopy; Cytology; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CARCINOGENICITY; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOLOGY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; REPRODUCIBILITY; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS EXAMINATION; VIRUS LOAD; WART VIRUS;

EID: 0038170274     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.456     Document Type: Article

References (10)

1. Solomon D, Schiffman M, Tarone R, ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
2. ALTS Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
3. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
4. ALTS Group. A randomized trial on the management of lowgrade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
5. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 981;17:1605-10.
6. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
7. Cox JT, Schiffman M, Solomon D, ALTS Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-12.
8. Schiffman M, Adrianza ME, ALTS Group. ASCUS-LSIL Triage Study: design, methods and characteristics of trial participants. Acta Cytol 2002;44:726-42.
9. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
10. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.